Diabetes and the COVID-19 Pandemic: What Should the Diabetes Patients Know?

When we compare intensive care unit (ICU) and non-ICU COVID-19 patients, the ICU cohort is twice as likely to have diabetes as the non-ICU cohort. [...]mortality is three times higher for COVID-19 patients with diabetes than other COVID-19 patients.9,10 There is a lack of recent studies showing the link between diabetes and COVID-19-related mortality. [...]taking these two drugs will increase ACE2, which will in turn facilitate infection by COVID-19.11,12 In 2006 a study showed the relation between plasma glucose levels and mortality in diabetic patients with SARS, which belongs to the same family as COVID-19. [...]it affects glycemic homeostasis and insulin sensitivity.13 Consequently, chronic hyperglycemia and inflammation statuses are responsible for the immunosuppression in type-2 diabetic patients that increases the risk of COVID-19 infection and mortality. [...]the patient should control their glucose level during infection to decrease the chances of superadded bacterial pneumonia. [...]constant hyperglycemia will damage the blood vessels in the human body, and therefore the circulatory system.